Study finds hand-held ultrasound device improves diagnosis of heart disease

GE Healthcare's Vscan hand-held ultrasound device--Courtesy of GE Healthcare.

Medical students who were trained to diagnose valvular heart disease using hand-held echocardiography technology performed better than students trained to diagnose the disease using only traditional methods, such as listening for heart murmurs with a stethoscope. Among students trained using only traditional methods, 40% correctly diagnosed valvular heart disease on the final exam, while 58% of those trained in the use of the ultrasound device were able to do so. Both sets of students were shown a video of echocardiograms. The device used in the study was GE Healthcare's ($GE) Vscan. The results were released at the American Heart Association meeting in Chicago. Release

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.